Phase III long-term administration study of Effexor XR [venlafaxine extended-release] for the treatment of depression
Phase of Trial: Phase III
Latest Information Update: 23 May 2007
At a glance
- Drugs Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Wyeth
- 23 May 2007 Status changed from recruiting to completed.
- 28 Aug 2006 New trial record.